CCCC - CIK 0001662579
The table below shows C4 Therapeutics, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q1 2023 | Q3 2022 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $61.27M | $58.81M | $78.16M | $51.29M | $59.65M | $49.55M |
| Short-term investments | - | - | - | - | - | $264.10M |
| Receivables | $2.88M | $6.54M | $2.16M | $8.03M | $10.34M | $1.49M |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $245.37M |
| $206.86M |
| $224.73M |
| $232.53M |
| $273.23M |
| $325.46M |
| Property, plant & equipment | $4.49M | $5.13M | $5.54M | $5.48M | $6.21M | $7.42M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $328.86M | $265.49M | $296.53M | $319.52M | $376.06M | $461.44M |
| Accounts payable | $773.00K | $1.33M | $2.22M | $683.00K | $1.50M | $2.37M |
| Total current liabilities | $27.25M | $35.95M | $44.46M | $40.82M | $43.29M | $45.27M |
| Long-term debt | - | - | - | - | $0.00 | $9.05M |
| Total liabilities | $94.61M | $111.08M | $122.46M | $124.38M | $133.40M | $143.26M |
| Retained earnings | -$763.82M | -$718.21M | -$686.04M | -$660.02M | -$599.13M | -$358.70M |
| Total equity | $234.25M | $154.41M | $174.06M | $195.14M | $242.66M | $318.18M |